JP2005505270A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505270A5
JP2005505270A5 JP2003526345A JP2003526345A JP2005505270A5 JP 2005505270 A5 JP2005505270 A5 JP 2005505270A5 JP 2003526345 A JP2003526345 A JP 2003526345A JP 2003526345 A JP2003526345 A JP 2003526345A JP 2005505270 A5 JP2005505270 A5 JP 2005505270A5
Authority
JP
Japan
Prior art keywords
antigen
cell
interleukin
cells
dendritic cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003526345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005505270A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/028620 external-priority patent/WO2003022215A2/en
Publication of JP2005505270A publication Critical patent/JP2005505270A/ja
Publication of JP2005505270A5 publication Critical patent/JP2005505270A5/ja
Pending legal-status Critical Current

Links

JP2003526345A 2001-09-06 2002-09-06 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法 Pending JP2005505270A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31759201P 2001-09-06 2001-09-06
PCT/US2002/028620 WO2003022215A2 (en) 2001-09-06 2002-09-06 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011148711A Division JP5777956B2 (ja) 2001-09-06 2011-07-04 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Publications (2)

Publication Number Publication Date
JP2005505270A JP2005505270A (ja) 2005-02-24
JP2005505270A5 true JP2005505270A5 (enExample) 2005-12-08

Family

ID=32654226

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003526345A Pending JP2005505270A (ja) 2001-09-06 2002-09-06 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法
JP2011148711A Expired - Fee Related JP5777956B2 (ja) 2001-09-06 2011-07-04 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法
JP2015040165A Expired - Fee Related JP6114768B2 (ja) 2001-09-06 2015-03-02 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011148711A Expired - Fee Related JP5777956B2 (ja) 2001-09-06 2011-07-04 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法
JP2015040165A Expired - Fee Related JP6114768B2 (ja) 2001-09-06 2015-03-02 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Country Status (17)

Country Link
US (2) US20050059151A1 (enExample)
EP (3) EP2322603B1 (enExample)
JP (3) JP2005505270A (enExample)
KR (3) KR20110081341A (enExample)
CN (2) CN102973928B (enExample)
AU (1) AU2008221592B2 (enExample)
BR (1) BRPI0212545B8 (enExample)
CA (1) CA2459713C (enExample)
DK (2) DK2322603T3 (enExample)
ES (2) ES2766299T3 (enExample)
IL (3) IL160720A0 (enExample)
MX (1) MXPA04002147A (enExample)
NO (2) NO338147B1 (enExample)
NZ (1) NZ531530A (enExample)
PL (1) PL372098A1 (enExample)
PT (2) PT1441591T (enExample)
WO (1) WO2003022215A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT412145B (de) * 2002-09-13 2004-10-25 Forsch Krebskranke Kinder Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen
US20040057935A1 (en) * 2002-09-20 2004-03-25 Cedars-Sinai Medical Center Intratumoral delivery of dendritic cells
WO2004053072A2 (en) * 2002-12-06 2004-06-24 Northwest Biotherapeutics, Inc. Administration of dendritic cells partially matured in vitro for the treatment of tumors
DK1604016T3 (da) * 2003-02-27 2009-05-18 Northwest Biotherapeutics Inc In vitro-fremgangsmåde til differentiering af monocytiske dendritiske precursorceller i umodne dendritiske celler
EP1484064A1 (en) 2003-06-04 2004-12-08 Gesellschaft für Biotechnologische Forschung Therapeutical composition containing dentritic cells and use thereof
EP1670513B1 (en) * 2003-10-06 2013-01-23 Cedars-Sinai Medical Center Cox-2 inhibitors and dendritic cells for use in the treatment of cancer.
WO2005043155A1 (en) * 2003-10-21 2005-05-12 Cedars-Sinai Medical Center System and method for the treatment of cancer, including cancers of the central nervous system
JPWO2005042737A1 (ja) * 2003-11-04 2007-05-10 株式会社ディナベック研究所 遺伝子導入された樹状細胞の製造方法
CA2571849A1 (en) 2004-06-24 2006-01-05 Dnavec Research Inc. Anticancer agent containing dendritic cell having rna virus transferred thereinto
KR20150082688A (ko) * 2005-12-08 2015-07-15 노쓰웨스트 바이오써라퓨틱스, 인크. 미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한 조성물 및 방법
EP1840206A1 (en) * 2006-03-28 2007-10-03 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Compositions for the preparation of mature dendritic cells
CA2700573C (en) * 2006-09-26 2016-11-22 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
WO2008039974A2 (en) 2006-09-28 2008-04-03 Cedars-Sinai Medical Center Cancer vaccines and vaccination methods
ES2565779T3 (es) * 2008-09-02 2016-04-06 Cedars-Sinai Medical Center Epítopos CD133
WO2010129895A2 (en) * 2009-05-07 2010-11-11 Immunocellular Therapeutics, Ltd. Cd133 epitopes
CN104540937A (zh) * 2012-02-02 2015-04-22 新干细胞肿瘤学有限责任公司 多能胚层起源抗原呈递癌症疫苗
CN104379730B (zh) * 2012-05-31 2016-12-14 Jw可瑞基因株式会社 使树突细胞成熟的组合物以及用其制备抗原特异性树突细胞的方法
US20140065173A1 (en) * 2012-09-06 2014-03-06 Orbis Health Solutions Llc Tumor lysate loaded particles
AU2020203845C1 (en) * 2012-09-06 2022-08-11 Orbis Health Solutions, Llc Tumor lysate loaded particles
CA2891602C (en) 2012-12-12 2017-10-24 Orbis Health Solutions, Llc Composition comprising an orthosilicate and its use for tissue regeneration
US10137182B2 (en) 2013-02-14 2018-11-27 Immunocellular Therapeutics, Ltd. Cancer vaccines and vaccination methods
CN104936612B (zh) * 2013-09-05 2021-01-01 奥比思健康解决方案有限责任公司 装载了肿瘤裂解物的微粒
CA2941633C (en) 2014-03-05 2021-01-12 Orbis Health Solutions Llc Vaccine delivery systems using yeast cell wall particles
US9767516B1 (en) 2014-05-20 2017-09-19 State Farm Mutual Automobile Insurance Company Driver feedback alerts based upon monitoring use of autonomous vehicle
US11669090B2 (en) 2014-05-20 2023-06-06 State Farm Mutual Automobile Insurance Company Autonomous vehicle operation feature monitoring and evaluation of effectiveness
US10599155B1 (en) 2014-05-20 2020-03-24 State Farm Mutual Automobile Insurance Company Autonomous vehicle operation feature monitoring and evaluation of effectiveness
US10373259B1 (en) 2014-05-20 2019-08-06 State Farm Mutual Automobile Insurance Company Fully autonomous vehicle insurance pricing
US9972054B1 (en) 2014-05-20 2018-05-15 State Farm Mutual Automobile Insurance Company Accident fault determination for autonomous vehicles
US9783159B1 (en) 2014-07-21 2017-10-10 State Farm Mutual Automobile Insurance Company Methods of theft prevention or mitigation
US10831204B1 (en) 2014-11-13 2020-11-10 State Farm Mutual Automobile Insurance Company Autonomous vehicle automatic parking
CN114774356A (zh) * 2015-06-30 2022-07-22 西北生物治疗药物公司 诱发改善的或增加的抗肿瘤免疫应答的经最佳活化的树突细胞
WO2017002045A1 (en) 2015-06-30 2017-01-05 Stemlab, Sa A viable cell population, method for production and uses thereof
US9805601B1 (en) 2015-08-28 2017-10-31 State Farm Mutual Automobile Insurance Company Vehicular traffic alerts for avoidance of abnormal traffic conditions
US10324463B1 (en) 2016-01-22 2019-06-18 State Farm Mutual Automobile Insurance Company Autonomous vehicle operation adjustment based upon route
US10395332B1 (en) 2016-01-22 2019-08-27 State Farm Mutual Automobile Insurance Company Coordinated autonomous vehicle automatic area scanning
US11719545B2 (en) 2016-01-22 2023-08-08 Hyundai Motor Company Autonomous vehicle component damage and salvage assessment
US10824145B1 (en) 2016-01-22 2020-11-03 State Farm Mutual Automobile Insurance Company Autonomous vehicle component maintenance and repair
US11441916B1 (en) 2016-01-22 2022-09-13 State Farm Mutual Automobile Insurance Company Autonomous vehicle trip routing
US10134278B1 (en) 2016-01-22 2018-11-20 State Farm Mutual Automobile Insurance Company Autonomous vehicle application
US11242051B1 (en) 2016-01-22 2022-02-08 State Farm Mutual Automobile Insurance Company Autonomous vehicle action communications
KR102038114B1 (ko) * 2016-02-26 2019-10-30 주식회사 엘지화학 광학 점착제용 (메타)아크릴레이트기 함유 벤조페논의 제조방법 및 광학 점착제 조성물
WO2018160666A1 (en) * 2017-02-28 2018-09-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Short-term activated dc1s and methods for their production and use
WO2019183924A1 (en) * 2018-03-30 2019-10-03 Syz Cell Therapy Co. Improved multiple antigen specific cell therapy methods
CA3157004A1 (en) * 2019-10-07 2021-04-15 Northwest Biotherapeutics, Inc. In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162504A (en) 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5366866A (en) * 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
US5227471A (en) * 1992-01-30 1993-07-13 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma
US5788963A (en) 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
EA199800272A1 (ru) * 1995-10-04 1998-10-29 Иммунекс Корпорейшн Фактор, стимулирующий дендритные клетки
US7659119B2 (en) * 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
ATE428769T1 (de) * 1997-10-27 2009-05-15 Univ Rockefeller Methode und zusammensetzung zur herstellung von reifen dendritischen zellen
JP2000143534A (ja) * 1998-11-13 2000-05-23 Asahi Chem Ind Co Ltd 樹状細胞ワクチン及びその製造方法
JP2000279181A (ja) * 1999-04-01 2000-10-10 Japan Science & Technology Corp ヒト樹状細胞の発現遺伝子群
WO2001048154A1 (en) * 1999-12-28 2001-07-05 Toyoshima, Kumao Maturation-promoting agent for immature dendritic cells
US6247378B1 (en) * 2000-01-06 2001-06-19 Deere & Company Operator control device for an infinitely variable transmission
JP4841794B2 (ja) * 2000-05-12 2011-12-21 ノースウエスト バイオセラピューティクス,インコーポレイティド ヒト樹状細胞による外因性抗原のクラスi提示を増加させる方法
JP2004520033A (ja) * 2001-01-15 2004-07-08 イ・デ・エム・イミュノ−デジネ・モレキュル 分化拘束された成熟樹状細胞の調製用補助組成物
WO2003010292A2 (en) * 2001-07-25 2003-02-06 Northwest Biotherapeutics, Inc. Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors

Similar Documents

Publication Publication Date Title
JP2005505270A5 (enExample)
JP2011188872A5 (enExample)
JP5777956B2 (ja) 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法
Boullart et al. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
JP3631496B2 (ja) 樹状細胞刺激因子
EP2531216B1 (en) Icos critically regulates the expansion and function of inflammatory human th17 cells
CN100337686C (zh) 从前体产生加载有抗原的树突细胞疫苗的快速一步法
Hou et al. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins
JP2014511704A5 (enExample)
US20010026937A1 (en) Monocyte-derived dendritic cell subsets
AU2003214566A1 (en) Functionalization of T cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
Zhang et al. Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival
US20040022761A1 (en) Compositions and methods for producing antigen-presenting cells
CA2321173A1 (en) Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
JP2025504109A (ja) Ebv複合抗原、樹状細胞ワクチンおよびその使用
Citterio et al. Dendritic cells as natural adjuvants
Telemo et al. Antigen presentation and processing in the intestinal mucosa and lymphocyte homing
Onaitis et al. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy
EP1280889B1 (en) Compositions and methods for producing antigen-presenting cells
CN1686538A (zh) 负载凋亡的热休克肿瘤细胞的树突状细胞肿瘤疫苗及其制备方法与应用
US20090060946A1 (en) Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
JP2002069001A (ja) 樹状細胞を主成分とする細胞ワクチン
JP2002500872A5 (enExample)
CN113444688A (zh) 用于抗病毒抗肿瘤的人树突状细胞诱导方法及组合物
US20080286315A1 (en) Methionine Enkephalin as an Adjuvant for Vaccine Immunizations